Explore Cell Therapy
by National Marrow Donor Program/Be The Match
January 15, 2025 5:35 am
In Explore Cell Therapy, we dig into the latest cell and gene therapy research and best practices to help you advance care for patients with hematologic malignancies and disorders. You’ll hear interviews with well-known and up-and-coming physicians in the hematopoietic stem cell transplantation (HCT) and cell and gene therapy field. You’ll receive insights from the National Marrow Donor Program® and our partners into what it takes to connect patients to the best available therapies. In season 2, we examine practice-changing research and hot topics in HCT and other cellular therapies. You’ll hear conversations with experts who specialize in HCT and at hematology/oncology practices.
Recent Episodes
14 - HCT Across MDS Genetic Subtypes, Part I: Expanding Access to Older Patients
6 months ago14 - HCT Across MDS Genetic Subtypes, Part II: The Role of Genetics and Early Consult
6 months ago13 - Optimizing Donor Searches in HCT, Part II: Overcoming Barriers
8 months ago13 - Optimizing Donor Searches in HCT, Part I: Strategies and Considerations
8 months ago12 - Streamlining HCT Referrals, Part I: Overcoming Barriers through Coordinated Care
11 months ago12- Streamlining HCT Referrals, Part II: Assessing the Impact and Future State
11 months ago11 - First-line BMT for Severe Aplastic Anemia, Pt. 2: Future Research and Care Coordination
1 year ago11 - First-line BMT for Severe Aplastic Anemia, Pt. 1: Outcomes and Equity
1 year ago10 – Trends in HCT Equity, Access and Outcomes, Pt. 2: Personalization and Future Care
1 year ago10 – Trends in HCT Equity, Access and Outcomes, Pt. 1: Improvements and Challenges
1 year ago